par Hanauske, Axel-R;Dumez, Herlinde;Piccart-Gebhart, Martine
;Yilmaz, Emine;Graefe, Tobias;Gil, Thierry
;Simms, Lorinda;Musib, Luna;Awada, Ahmad 
Référence Investigational new drugs, 27, 4, page (356-365)
Publication Publié, 2009-08



Référence Investigational new drugs, 27, 4, page (356-365)
Publication Publié, 2009-08
Article révisé par les pairs
Titre: |
|
Auteur: | Hanauske, Axel-R; Dumez, Herlinde; Piccart-Gebhart, Martine; Yilmaz, Emine; Graefe, Tobias; Gil, Thierry; Simms, Lorinda; Musib, Luna; Awada, Ahmad |
Informations sur la publication: | Investigational new drugs, 27, 4, page (356-365) |
Statut de publication: | Publié, 2009-08 |
Sujet CREF: | Sciences bio-médicales et agricoles |
Mots-clés: | Combination chemotherapy |
Paclitaxel | |
Pemetrexed | |
Phase I | |
Vitamin supplementation | |
MeSH keywords: | Adult |
Aged | |
Antineoplastic Combined Chemotherapy Protocols -- administration & dosage | |
Antineoplastic Combined Chemotherapy Protocols -- adverse effects | |
Antineoplastic Combined Chemotherapy Protocols -- pharmacokinetics | |
Dose-Response Relationship, Drug | |
Drug Administration Schedule | |
Female | |
Glutamates -- administration & dosage | |
Guanine -- administration & dosage | |
Guanine -- analogs & derivatives | |
Humans | |
Male | |
Maximum Tolerated Dose | |
Mesothelioma -- drug therapy | |
Middle Aged | |
Neoplasms -- drug therapy | |
Paclitaxel -- administration & dosage | |
Thyroid Neoplasms -- drug therapy | |
Young Adult | |
Note générale: | Clinical Trial, Phase I |
Journal Article | |
Research Support, Non-U.S. Gov't | |
Langue: | Anglais |
Identificateurs: | urn:issn:0167-6997 |
info:doi/10.1007/s10637-008-9193-5 | |
info:scp/67651159193 | |
info:pmid/18956139 |